Effects of Circuit Residual Volume Salvage Reinfusion on the Postoperative Clinical Outcome for Pediatric Patients Undergoing Cardiac Surgery

Ye, LiFen; Lin, Ru; Fan, Yong; Yang, LiJun; Hu, JianLing; Shu, Qiang
June 2013
Pediatric Cardiology;Jun2013, Vol. 34 Issue 5, p1088
Academic Journal
This study aimed to evaluate the effects of washed cardiopulmonary (CPB) circuit residual blood reinfusion on the postoperative clinical outcome for pediatric patients undergoing cardiac surgery. A total of 309 consecutive Chinese cardiac patients receiving CPB between October 2010 and April 2011 were prospectively analyzed. For 217 patients, CPB circuit residual blood was reinfused after the cell-saving procedure [cell-salvage group (CS)]. The remaining 92 patients were directly transfused with allogenic red blood cells (RBCs) after their operation [control group (CON)]. Assessment included perioperative transfusion of RBCs, postoperative hematocrit (HCT), chest tube drainage during the first 24 h after the operation, intrahospital mortality, respiratory morbidity, and renal dysfunction. The two groups were well matched in terms of demographics, CPB data, and complexity of surgical procedure. The patients in the CS group had a significantly higher HCT level postoperatively ( p = 0.018) and a less allogenic RBCs transfusion ( p = 0.000). The two groups did not differ in terms of chest tube drainage during the first 24 h postoperatively, intrahospital mortality, or respiratory morbidity. The incidence of serum creatinine (≥2-folds) during the first 72 h after the operation was significantly lower in the CS group (2.3 %) than in the CON group (8.7 %) ( p = 0.010). Reinfusion of washed CPB circuit residual blood significantly raised the postoperative HCT level, reduced the allogeneic blood transfusion, decreased the incidence of early postoperative renal dysfunction, and did not increase the chest tube drainage after the operation in pediatric cardiac surgery.


Related Articles

  • Remote ischaemic preconditioning protects against cardiopulmonary bypass-induced tissue injury: a preclinical study. Kharbanda, R. K.; Li, J.; Konstantinov, I. E.; Cheung, M. M. H.; White, P. A.; Frndova, H.; Stokoe, J.; Cox, P.; Vogel, M.; van Arsdell, G.; MacAllister, R.; Redington, A. N. // Heart;Oct2006, Vol. 92 Issue 10, p1506 

    Objectives: To test the hypothesis that remote ischaemic preconditioning (rIPC) reduces injury after cardiopulmonary bypass (CPB). Design: Randomised study with an experimental model of CPB (3 h CPB with 2 h of cardioplegic arrest). Twelve 15 kg pigs were randomly assigned to control or rIPC...

  • Moderate dosage of tranexamic acid during cardiac surgery with cardiopulmonary bypass and convulsive seizures: incidence and clinical outcome. Koster, A.; Börgermann, J.; Zittermann, A.; Lueth, J. U.; Gillis-Januszewski, T.; Schirmer, U. // BJA: The British Journal of Anaesthesia;Jan2013, Vol. 110 Issue 1, p34 

    Background Convulsive seizures (CS) occur in ∼1% of the patients after cardiac surgery with cardiopulmonary bypass. Recent investigations indicate an up to seven-fold increase in CS in cardiac surgical patients receiving high doses (≥60 mg kg−1 body weight) of tranexamic acid...

  • Complete mechanical circulatory support using ventricular assist devices for post-cardiotomy biventricular failure. Nwaejike, Nnamdi; Bonde, Pramod; Campalani, Gianfranco // Ulster Medical Journal;2008, Vol. 77 Issue 1, p36 

    Cardiopulmonary bypass (CPB) allows operations on the heart in a motionless and bloodless field while reducing cardiac workload and sustaining systemic and coronary perfusion. Failure to wean from CPB remains a significant problem. Results from recent large registry data have shown dramatic...

  • ICU outcomes in adult cardiac surgery patients in relation to ultrafiltration type. Pérez-Vela, J. L.; Ruiz-Alonso, E.; Guillén-Ramírez, F.; García-Maellas, M. T.; Renes-Carreño, E.; Cerro-García, M.; Cortina-Romero, J.; Hernández-Rodríguez, I. // Perfusion;Mar2008, Vol. 23 Issue 2, p79 

    Ultrafiltration (UF) is used to ameliorate the deleterious effects of cardiopulmonary bypass (CPB) in cardiac surgery patients. There are two different methods; conventional ultrafiltration (CUF), performed during CPB, and modified ultrafiltration (MUF), performed after CPB is finished. It has...

  • Single-Centre Experience with Perioperative Use of Intraaortic Balloon Pump in Cardiac Surgery. Kucuker, Aslihan; Cetin, Levent; Kucuker, Seref Alp; Gokcimen, Mecit; Hidiroglu, Mete; Kunt, Aysegul; Saglam, Fethi; Sener, Erol // Heart, Lung & Circulation;May2014, Vol. 23 Issue 5, p475 

    Background: Intraaortic balloon pump (IABP) is frequently used in cardiac surgery in order to prevent or treat low cardiac output syndrome. Although being widely used and forming the first line therapy in these haemodynamically unstable patients despite maximal medication, optimal timing for...

  • The Hemobag: the modern ultrafiltration system for patients undergoing cardiopulmonary by pass. Colli, Andrea; Balduzzi, Sara; Ruyra, Xavier // Journal of Cardiothoracic Surgery;2012, Vol. 7 Issue 1, p55 

    Background: The return of extracorporeal circuit blood at the termination of cardiopulmonary bypass (CPB) is an important feature of blood conservation during cardiac surgery procedures globally. We report our initial clinical evaluation of the Hemobag system a blood-salvaging device designed...

  • Switch from aprotinin to É›-aminocaproic acid: impact on blood loss, transfusion, and clinical outcome in neonates undergoing cardiac surgery. Martin, K.; Gertler, R.; Liermann, H.; Mayr, N. P.; MacGuill, M.; Schreiber, C.; Vogt, M.; Tassani, P.; Wiesner, G. // BJA: The British Journal of Anaesthesia;Dec2011, Vol. 107 Issue 6, p934 

    Background With the withdrawal of aprotinin from worldwide marketing in November 2007, many institutions treating patients at high risk for hyperfibrinolysis had to update their therapeutic protocols. At our institution, the standard was switched from aprotinin to É›-aminocaproic acid (EACA)...

  • Staged surgical management of hypoplastic left heart syndrome: a single institution 12 year experience. McGuirk, S. P.; Griselli, M.; Stumper, O. F.; Rumball, E. M.; Miller, P.; Dhillon, R.; de Giovanni, J. V.; Wright, J. G.; Barron, D. J.; Brawn, W. J. // Heart;Mar2006, Vol. 92 Issue 3, p364 

    Objective: To describe a 12 year experience with staged surgical management of the hypoplastic left heart syndrome (HLHS) and to identify the factors that influenced outcome. Methods: Between December 1992 and June 2004, 333 patients with HLHS underwent a Norwood procedure (median age 4 days,...

  • The interpretation of perioperative lactate abnormalities in patients undergoing cardiac surgery. O'connor, E.; Fraser, J. F. // Anaesthesia & Intensive Care;Jul2012, Vol. 40 Issue 4, p598 

    The article offers clinical information on hyperlactataemia (HL) and lactic acidosis, which are common during and after cardiac surgery. It describes lactate physiology in relation to cardiac surgery, and illustrates the relationship between the onset of HL and patient outcomes. The...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics